CORONA Remedies Ltd.

₹2230.6

+ 30.45 (1.38%)

04:01 pm - close price

BSE: CORONA

NSE: CORONA

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 30.27Good: 5

✅

Adjusted EPS

Bad: 3Current: 30.27Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 31.74Good: 20

✅

Current Ratio

Bad: 1Current: 0.97Good: 2

❌

Return On Equity (ROE)

Bad: 5Current: 27.36Good: 15

✅

Debt to Total Assets

Bad: 1Current: 11.00Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 30.27Good: 5

✅

Adjusted EPS

Bad: 3Current: 30.27Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 31.74Good: 20

✅

Current Ratio

Bad: 1Current: 0.97Good: 2

❌

Return On Equity (ROE)

Bad: 5Current: 27.36Good: 15

✅

Debt to Total Assets

Bad: 1Current: 11.00Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Profit & Loss

In Rs. Cr.	202303	202403	202503	202603
Sales	8840.50	10144.74	1196.42	1403.18
Operational Expenses+	7560.71	8597.41	956.44	1109.74
Operating Profit	1279.79	1547.33	239.98	293.44
Other Income	70.51	64.57	5.93	10.65
OPM %	14.48	15.25	20.06	20.91
Depreciation and Amortisation	201.03	282.78	37.16	37.87
Interest	42.68	144.37	10.60	6.97
Profit Before Tax	1108.87	1184.81	198.53	240.42
Tax	259.58	314.97	49.85	60.02
Net Profit	849.29	905.03	149.43	185.12

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	-	6626.62	8751.95	1017.37	1298.50
Liabilities+	0.00	6626.62	8751.95	1017.37	1298.50

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	-	1027.00	1567.58	190.49	229.48
Cash from Investing Activity	-	-502.45	-2666.43	-83.86	-256.15
Cash from Financing Activity	-	-447.47	985.45	-106.57	25.28
Net Cash Flow	-	77.08	-113.40	0.06	-1.39
Opening Cash & Cash Equivalents	-	68.24	144.94	3.16	3.22
Closing Cash & Cash Equivalents	-	144.94	31.56	3.22	1.83

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25
Promoters+	69.00	69.00	69.00	69.00
Public+	31.00	31.00	31.00	31.00
Custodians	0.00	0.00	0.00	0.00
Number of Shareholders	20185	19609	31035	159545

Corporate Actions

99 events in the last 3 years

Profit & Loss

In Rs. Cr.	202303	202403	202503	202603
Sales	8840.50	10144.74	1196.42	1403.18
Operational Expenses+	7560.71	8597.41	956.44	1109.74
Operating Profit	1279.79	1547.33	239.98	293.44
Other Income	70.51	64.57	5.93	10.65
OPM %	14.48	15.25	20.06	20.91
Depreciation and Amortisation	201.03	282.78	37.16	37.87
Interest	42.68	144.37	10.60	6.97
Profit Before Tax	1108.87	1184.81	198.53	240.42
Tax	259.58	314.97	49.85	60.02
Net Profit	849.29	905.03	149.43	185.12

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	-	6626.62	8751.95	1017.37	1298.50
Liabilities+	0.00	6626.62	8751.95	1017.37	1298.50

Ratios

Reported EPS

Bad: 2Current: 30.27Good: 5

✅

Adjusted EPS

Bad: 3Current: 30.27Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 31.74Good: 20

✅

Current Ratio

Bad: 1Current: 0.97Good: 2

❌

Return On Equity (ROE)

Bad: 5Current: 27.36Good: 15

✅

Debt to Total Assets

Bad: 1Current: 11.00Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 30.27Good: 5

✅

Adjusted EPS

Bad: 3Current: 30.27Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 31.74Good: 20

✅

Current Ratio

Bad: 1Current: 0.97Good: 2

❌

Return On Equity (ROE)

Bad: 5Current: 27.36Good: 15

✅

Debt to Total Assets

Bad: 1Current: 11.00Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25
Promoters+	69.00	69.00	69.00	69.00
Public+	31.00	31.00	31.00	31.00
Custodians	0.00	0.00	0.00	0.00
Number of Shareholders	20185	19609	31035	159545

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	-	1027.00	1567.58	190.49	229.48
Cash from Investing Activity	-	-502.45	-2666.43	-83.86	-256.15
Cash from Financing Activity	-	-447.47	985.45	-106.57	25.28
Net Cash Flow	-	77.08	-113.40	0.06	-1.39
Opening Cash & Cash Equivalents	-	68.24	144.94	3.16	3.22
Closing Cash & Cash Equivalents	-	144.94	31.56	3.22	1.83

CORONA Remedies Ltd.

₹2230.6

+ 30.45 (1.38%)

04:01 pm - close price

BSE: CORONA

NSE: CORONA

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Corporate Actions

99 events in the last 3 years